Form 4 for NAUT Nautilus Biotechnology, Inc.
Accepted 2021-08-13 00:00:00 ET · period of report 2021-08-13 · accession 0001808805-21-000010 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2021-08-13 | 2021-08-13 | NAUT | Murphy Matthew B. | GC | P - Purchase | $7.56 | +5,000 | 34.1K | +17% | +$37.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-13 | P | A | 5,000 | $7.56 | 34,140 | I See Footnote | — | — | (F1) Shares held by the Murphy Family Trust. The Reporting Person is the Trustee of the Murphy Family Trust. |